OPKO Health (OPK) Tops Q2 EPS by 6c

OPKO Health (NASDAQ: OPK) reported Q2 EPS of ($0.01), $0.06 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $263.7 million versus the consensus estimate of $261.65 million.

For earnings history and earnings-related data on OPKO Health (OPK) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• UBS: 'We Believe Dollar Tree (DLTR) is Turning From a Transformation to a Growth Story'
• Benchmark Reiterates Buy Rating on Odysight.AI Inc. (ODYS)